Latest On-Demand Webinars & Online Events

This exclusive Q&A event invites you to ask anything about the world of predatory conferences to our expert speaker.

In this webinar, Scalable production of AAV from shake flasks to 1,000 L single use bioreactors using the Gibco™ CTS™ AAV‑MAX Production System, Jon Zmuda from Thermo Fisher Scientific will share several case studies

This talk delves into the fascinating world of aptamers. Aptamers are short single-stranded nucleic acid oligomers, either DNA or RNA, known for their ability to form intricate three-dimensional structures. The development of aptamers relies on SELEX (systematic evolution of ligands by exponential enrichment), a process that allows researchers to fine-tune their characteristics during selection.

This one-day online event will feature short talks covering recent innovations in research and technology in the cell and gene therapy domain. Our expert panel of presenters will address key advances across the entire R&D pipeline, from pre-clinical work right through to bioprocessing and manufacturing.

An incredible opportunity to ask the Chief Editor of Nature on how to get published in high-ranking journals.

This webinar showcases the latest live-cell metabolic analysis technologies for the detection of cellular bioenergetic changes in human immune cells. It demonstrates real-world applications for the development and testing of life-saving therapeutics.

This webinar discusses the role of smart technology and how this can mitigate human error and support compliance effectively in QA/QC labs.

In this webinar, our expert speakers will explore the vital role of qPCR and digital PCR in supporting advanced therapy medicinal products, including cell therapies. Discover best practices for assay design, validation parameters and acceptance criteria crucial for ensuring the safety and efficacy of cell therapy programs. Learn how molecular precision can safeguard these innovative therapies and drive breakthroughs in the field.

Protein stability is one of the most important critical quality attributes for a new biological drug. Unstable or misfolded proteins are prone to aggregation and precipitation, which can lead to lower activity as well as increased immunogenicity. There has been a long-standing interest in renaturing unfolded, misfolded or precipitated proteins.

In this webinar, our expert speakers will demonstrate how thermal and pressure stress changed the structure and melting point of two model proteins and resulted in the discovery of different structural rearrangements.

They will then discuss a novel method for solubilizing and refolding proteins using hydrostatic pressure to generate proteins whose structure matches that of the native protein, as confirmed by microfluidic modulation spectroscopy.

In this webinar, we’ll discuss the challenges, risks and considerations involved in developing and using in-house residual testing solutions, and the benefits of using commercial kits for residual DNA testing, including shorter process development time, simplified regulatory acceptance and how they help to enable focus on process-specific development tasks.